title: RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials.
authors.affiliation: Department of Biochemistry and Microbiology, Marshall University School of Medicine, Huntington, West Virginia, USA. hardmanw@marshall.edu
authors.forename: Theodore R
authors.initials: TR
authors.lastname: Witte
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Salazar
authors.forename: Oscar F
authors.initials: OF
authors.lastname: Ballester
authors.forename: W Elaine
authors.initials: WE
authors.lastname: Hardman
mesh_terms: D002986:Clinical Trials as Topic; D019587:Dietary Supplements; D018450:Disease Progression; D004912:Erythrocytes / Q000166:cytology*; D005227:Fatty Acids / Q000737:chemistry / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000378:metabolism*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D007962:Leukocytes / Q000166:cytology*; D008055:Lipids / Q000737:chemistry; D016328:NF-kappa B / Q000096:biosynthesis*; D010865:Pilot Projects
chemical_list: D005227:Fatty Acids; D015525:Fatty Acids, Omega-3; D008055:Lipids; D016328:NF-kappa B